2021
Short-term complications of percutaneous biliary interventions in patients with cholangiocarcinoma in dependence on presence of gastroenteroanastomosis
STRAKA, Matej; Tomáš ROHAN; Tomáš ANDRAŠINA; Peter MATKULČÍK; Martin SVOBODA et al.Základní údaje
Originální název
Short-term complications of percutaneous biliary interventions in patients with cholangiocarcinoma in dependence on presence of gastroenteroanastomosis
Autoři
Vydání
2021
Další údaje
Jazyk
angličtina
Typ výsledku
Konferenční abstrakt
Obor
30224 Radiology, nuclear medicine and medical imaging
Stát vydavatele
Německo
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/21:00120219
Organizační jednotka
Lékařská fakulta
Klíčová slova anglicky
percutaneous transhepatic drainage; biliary tract; benign stenosis; hepaticojejunoanastomosis
Příznaky
Mezinárodní význam
Změněno: 29. 1. 2022 15:38, MUDr. Tomáš Rohan, Ph.D.
Anotace
V originále
Purpose: To analyze short-term complications rate after percutaneous biliary drainage (PTD) in cholangiocarcinoma (CCC) in relation to history of surgically performed gastroenteroanastomosis (GEA) Materials and Methods: 136 patients with CCC with palliative percutaneous interventions (i.e. PTD, brachytherapy, stent implantations) performed between 2005-2019 were enrolled in this single center retrospective study. Study group consists of patients with GEA performed prior to percutaneous biliary intervention (n=8). Control group consists of 128 patients with CCC without history of any prior hepatobilliary surgical procedure. 30 day complication rate (i.e. biliary leakage, bilioma formation, haemobilia, etc.) after percutaneous intervention was assessed. Complications per patient and complication per procedure in both groups were compared (Chi-Square Test). Results: A total of 386 percutaneous transhepatic interventions were performed, 27 in GEA and 359 in control group (average 3.37 vs 2.82 per patient). Metal stent was implanted in 88% of patients with GEA and in 54% of control group (p=0.33), brachytherapy was performed in 38% and 43% of patients (p=0.87). Overall complication rate per procedure and per patient was 11.3% and 22.0%, respectively. Signifcant diference in complication rate per patient was observed (26% vs 10%; p=0.013), on the contrary, complication rate per procedure was not signifcant (38% vs 21%; p=0.28). Conclusion: Patients with CCC treated by paliative transhepatic procedures with history of GEA showed signifcantly higher rate of periprocedural complications
Návaznosti
| MUNI/A/1342/2020, interní kód MU |
| ||
| NU21-08-00561, projekt VaV |
|